로고

People 

유전자치료제 개발에 가장 경험이 풍부한 국내/외 최고 전문가들로 구성이 되었으며, 그 동안 쌓아온 기술력을 기반으로 향후 글로벌 10대 동물 바이오제약 회사로 발전해 갈 것 입니다.
  • C. Jo White
    MD
    전무이사

    (Head of Global Clinical Trials)

    I am Dr. Jo White and I have 30 years of experience in clinical development and regulatory affairs in the pharmaceutical industry. Prior to joining Plumbline, my work resulted in the licensing of 9 different human vaccines in the US and Europe. I have had senior management positions at 6 different pharmaceutical companies.

    I was the first Chief Medical Officer at Inovio, Plumbline’s parent company, which began the technology of delivering DNA vaccines by electroporation. My group at Inovio began the early clinical studies in women which demonstrated the safety and efficacy of the DNA HPV vaccine delivered by electroporation for treatment of cervical cancer.

    I decided to join Plumbline USA to broaden my experience in developing cancer vaccines in companion animals.

    I see Plumbline as a leader in the development of cancer vaccines for companion animals and infectious diseases in herd animals. The US and Korean operations work together with our colleagues at the Wistar Institute and Inovio to reach these goals.

  • 양주성, Ph.D
    전무이사

    (Head of Global R&D)

    • 前 ㈜바이오니아 신약연구소장 상무이사
    • 前 성균관대학교 생명공학부 교수
    • Univ. of Pennsylvania Postdoctoral Fellow
    • North Carolina State Univ. Ph.D. 면역학
  • C. Jo White,
    MD 전무이사

    (Head of Global Clinical Trials)

    I am Dr. Jo White and I have 30 years of experience in clinical development and regulatory affairs in the pharmaceutical industry. Prior to joining Plumbline, my work resulted in the licensing of 9 different human vaccines in the US and Europe. I have had senior management positions at 6 different pharmaceutical companies.

    I was the first Chief Medical Officer at Inovio, Plumbline’s parent company, which began the technology of delivering DNA vaccines by electroporation. My group at Inovio began the early clinical studies in women which demonstrated the safety and efficacy of the DNA HPV vaccine delivered by electroporation for treatment of cervical cancer.

    I decided to join Plumbline USA to broaden my experience in developing cancer vaccines in companion animals.

    I see Plumbline as a leader in the development of cancer vaccines for companion animals and infectious diseases in herd animals. The US and Korean operations work together with our colleagues at the Wistar Institute and Inovio to reach these goals.

  • 양주성, Ph.D. 전무이사

    (Head of Global R&D)

    • 前 ㈜바이오니아 신약연구소장 상무이사
    • 前 성균관대학교 생명공학부 교수
    • Univ. of Pennsylvania Postdoctoral Fellow
    • North Carolina State Univ. Ph.D. 면역학